Stocky
ACLX
Arcellx, Inc.
NASDAQ NMS - GLOBAL MARKET · Biotechnology · US
115.07
▲ +0.02%

What's happening at Arcellx, Inc.

Arcellx, Inc.'s latest moves, explained simply — so you know why the numbers change.

Straight from SEC filings · updated 5 Aug 2026
Big update 28 Apr 2026

Company delisted from Nasdaq after merger completion

Stock trading stops and company ends reporting requirements after becoming owned by parent company.

SEC 8-K · filed 2026-04-28 View filing ↗
Earnings 26 Feb 2026

Annual financial report for year ended December 31 2025

Shows company's financial performance, assets, and business operations over the past year.

SEC 10-K · filed 2026-02-26 View filing ↗
Deal 23 Feb 2026

Merger agreement signed with parent company on February 22 2026

Company agreed to be acquired, giving shareholders the right to tender shares and receive payment.

SEC 8-K · filed 2026-02-23 View filing ↗

Common questions

How does Stocky track Arcellx, Inc.'s company events?

Stocky reads Arcellx, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.

What was Arcellx, Inc.'s most recent SEC filing?

Arcellx, Inc.'s most recent tracked filing was a 8-K on 28 Apr 2026: Company delisted from Nasdaq after merger completion.

Is this financial advice?

No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.

See Arcellx, Inc.'s full breakdown on Stocky →

Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 5 Aug 2026.